The patient pathway for mild cognitive impairment due to Alzheimer’s disease in Asia: Current practices, barriers, and expert recommendations for optimization

The survey findings showed that screening and diagnostic processes for mild cognitive impairment due to Alzheimer's disease in Asia require further optimization. Efforts should also be made to educate patients and caregivers, improve the diagnostic capabilities of primary and secondary healthcare providers, and reinforce cognitive screening services. The provision and reimbursement of confirmatory tests of amyloid burden should be expanded across the region to facilitate access to innovative disease-modifying therapies.

Authors

Institutions

Publication Details

Journal
The Journal of Prevention of Alzheimer s Disease
Published
2025-06-06
DOI
https://doi.org/10.1016/j.tjpad.2025.100215
Citations
2
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The patient pathway for mild cognitive impairment due to Alzheimer’s disease in Asia: Current practices, barriers, and expert recommendations for optimization

SangYun Kim, Ai‐Vyrn Chin, Paulus Anam Ong, Gandan Jiang et al.
2 citations
The Journal of Prevention of Alzheimer s Disease
Dementia and Cognitive Impairment Research
2.94
article

The patient pathway for mild cognitive impairment due to Alzheimer’s disease in Asia: Current practices, barriers, and expert recommendations for optimization

SangYun Kim, Ai‐Vyrn Chin, Paulus Anam Ong, Gandan Jiang, Vincent Mok, Christopher Chen, Jacqueline C. Dominguez, Amitabh Dash, Seong Hye Choi, Manjari Tripathi, Vorapun Senanarong, Chaur Jong Hu
article en
2 citations

Abstract

The survey findings showed that screening and diagnostic processes for mild cognitive impairment due to Alzheimer's disease in Asia require further optimization. Efforts should also be made to educate patients and caregivers, improve the diagnostic capabilities of primary and secondary healthcare providers, and reinforce cognitive screening services. The provision and reimbursement of confirmatory tests of amyloid burden should be expanded across the region to facilitate access to innovative disease-modifying therapies.

The Journal of Prevention of Alzheimer s DiseaseVol. 12(7)
University Malaya Medical Centre (MY), Siriraj Hospital (TH), National University of Singapore (SG), Chinese University of Hong Kong (HK), Inha University (KR), Mahidol University (TH), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), Dr. Hasan Sadikin General Hospital (ID), St. Luke's Medical Center (PH), Taipei Medical University (TW), Eisai (Japan) (JP), All India Institute of Medical Sciences (IN), Padjadjaran University (ID)
Openalex Percentile: Top 10%
Dementia and Cognitive Impairment Research
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.